Periventricular Leukomalacia

Periventricular leukomalacia (PVL) is injury to the white matter that lies adjacent to the cerebral ventricles in the preterm infant. Once defined chiefly by its cystic, necrotic form, it is now understood as the leading lesion underlying cerebral palsy and cognitive impairment in survivors of premature birth, with a diffuse, non-cystic component that is far more common than the classic cystic lesion.

Definition

Periventricular leukomalacia is injury to the cerebral white matter surrounding the lateral ventricles in the preterm infant, encompassing both focal necrotic (cystic) lesions and a more diffuse disturbance of myelination, and is a principal substrate of the neurodevelopmental sequelae of prematurity.

Scope

This entry covers the location and forms of periventricular white-matter injury, the selective vulnerability of the developing oligodendrocyte, the roles of ischemia and inflammation, and the relationship of the lesion to later motor and cognitive outcome. It is a reference description of the condition and its mechanisms and does not provide management protocols or individualized clinical advice.

Core questions

• Why is periventricular white matter selectively vulnerable in the preterm brain?
• How do cystic and diffuse forms of the injury differ?
• What roles do ischemia and inflammation play in its pathogenesis?
• How does periventricular leukomalacia relate to cerebral palsy?

Key concepts

• Periventricular white matter
• Pre-oligodendrocyte (oligodendrocyte precursor) vulnerability
• Cystic versus diffuse (non-cystic) injury
• Ischemia and arterial border zones
• Maternal-fetal infection and inflammation
• Disturbed myelination
• Spastic diplegia and cerebral palsy

Mechanisms

The hallmark of periventricular leukomalacia is the selective vulnerability of immature oligodendrocyte precursors (pre-oligodendrocytes), which populate periventricular white matter during the high-risk preterm window and are sensitive to injury from ischemia, free radicals, excitotoxicity, and inflammatory cytokines. Periventricular regions also lie in vascular border zones susceptible to falls in perfusion, and maternal-fetal infection and the fetal inflammatory response contribute to or amplify the injury. The resulting loss or maturational arrest of these cells disturbs subsequent myelination, producing the diffuse white-matter abnormality that dominates the modern lesion, with focal necrosis producing the cystic form. Volpe (2001, 2009) and Back (2017) develop this mechanistic account.

Clinical relevance

Because periventricular leukomalacia is a major substrate of cerebral palsy, especially spastic diplegia, and of cognitive and visual difficulties in former preterm infants, recognition of white-matter injury on neuroimaging informs prognosis and developmental follow-up. The material describes disease mechanisms and outcomes and is not a basis for individual diagnosis or management.

Epidemiology

Periventricular leukomalacia is a condition of preterm infants, concentrated in those born very preterm, and is the white-matter lesion most strongly linked to the later development of cerebral palsy in this population. While the overt cystic form has become less common with improvements in care, the diffuse non-cystic form remains frequent and is increasingly identified with magnetic resonance imaging (Volpe 2009; Back 2017).

Evidence & guidelines

Understanding of the lesion rests on neuropathological and neuroimaging studies and on mechanistic work identifying the pre-oligodendrocyte as the vulnerable cell, synthesized in influential reviews (Volpe 2001; Volpe 2009; Back 2017) and the standard neonatal neurology reference (Volpe et al. 2018). There is no specific disease-directed therapy, and the literature emphasizes prevention of contributing insults.

History

Periventricular leukomalacia was described pathologically in the late nineteenth and twentieth centuries as cystic necrosis of periventricular white matter in infants surviving prematurity. Late-twentieth- and early-twenty-first-century work reframed it as a broader disorder of the developing white matter, identifying the selective vulnerability of pre-oligodendrocytes and the contributions of ischemia and inflammation, and recognizing the predominance of a diffuse, non-cystic form revealed by magnetic resonance imaging.

Debates

How much do ischemia and inflammation each contribute?

Both reduced cerebral perfusion and maternal-fetal inflammation are implicated in white-matter injury, and their relative weight and interaction in any given infant remain an area of active investigation.

Key figures

• Joseph J. Volpe
• Stephen A. Back
• Linda S. de Vries

Seminal works

• volpe-pvl-2001
• volpe-2009
• back-2017

Frequently asked questions

Is periventricular leukomalacia always cystic?

No. The classic cystic form is now relatively uncommon; the more frequent presentation is a diffuse, non-cystic disturbance of the developing white matter that is best appreciated on magnetic resonance imaging.

Why is the preterm white matter so vulnerable?

During the preterm period the periventricular white matter is populated by immature oligodendrocyte precursors that are highly sensitive to ischemia, oxidative stress, and inflammation, so insults at this stage disrupt subsequent myelination.